ID18708A - LIGAN METABOTROPIC GLUTAMATE RECEPTORS - Google Patents

LIGAN METABOTROPIC GLUTAMATE RECEPTORS

Info

Publication number
ID18708A
ID18708A IDP972770A ID972770A ID18708A ID 18708 A ID18708 A ID 18708A ID P972770 A IDP972770 A ID P972770A ID 972770 A ID972770 A ID 972770A ID 18708 A ID18708 A ID 18708A
Authority
ID
Indonesia
Prior art keywords
ligan
metabotropic glutamate
glutamate receptors
receptors
metabotropic
Prior art date
Application number
IDP972770A
Other languages
Indonesian (id)
Inventor
Satoshi Hayashibe
Hirotsune Itahana
Kiyoshi Yahiro
Shin-Ichi Tsukamato
Hiroshi Yamashita
Masamichi Okada
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of ID18708A publication Critical patent/ID18708A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDP972770A 1996-08-09 1997-08-08 LIGAN METABOTROPIC GLUTAMATE RECEPTORS ID18708A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21127896 1996-08-09

Publications (1)

Publication Number Publication Date
ID18708A true ID18708A (en) 1998-04-30

Family

ID=16603285

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972770A ID18708A (en) 1996-08-09 1997-08-08 LIGAN METABOTROPIC GLUTAMATE RECEPTORS

Country Status (3)

Country Link
AU (1) AU3783497A (en)
ID (1) ID18708A (en)
WO (1) WO1998006724A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0891978T3 (en) * 1997-07-18 2002-07-01 Hoffmann La Roche 5H-thiazole (3,2-a) pyrimidinderivativer
EP1059090A4 (en) * 1998-03-03 2002-02-27 Yamanouchi Pharma Co Ltd Remedies for brain infarction
DK1064382T3 (en) 1998-03-17 2008-12-08 Genentech Inc Homologous polypeptides for VEGF and BMP1
AU2241400A (en) 1999-04-06 2000-10-12 Yamanouchi Pharmaceutical Co., Ltd. Novel thiazolobenzoimidazole derivative
DE19948434A1 (en) * 1999-10-08 2001-06-07 Gruenenthal Gmbh Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amines
WO2002062803A1 (en) * 2001-02-08 2002-08-15 Yamanouchi Pharmaceutical Co., Ltd. Thienopyrimidine derivative
TWI417095B (en) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
DK2001892T3 (en) 2006-03-17 2013-07-01 Ambit Biosciences Corp IMIDAZOLTHIAZOL COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES
SI2083811T1 (en) 2006-11-22 2017-02-28 Clinical Research Associates, Llc Methods of treating down's syndrome, fragile x syndrome and autism
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
PT2203439E (en) 2007-09-14 2011-02-11 Ortho Mcneil Janssen Pharm 1`,3`-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1`h-ý1, 4`¨bipyridinyl-2`-ones
TWI437988B (en) 2007-09-19 2014-05-21 Ambit Biosciences Corp Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
CA2735764C (en) 2008-09-02 2016-06-14 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
MX2011005242A (en) 2008-11-28 2011-09-06 Ortho Mcneil Janssen Pharm Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors.
EP2218464A1 (en) * 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides
MX2011011964A (en) 2009-05-12 2012-02-23 Janssen Pharmaceuticals Inc 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders.
AR076859A1 (en) 2009-05-12 2011-07-13 Ortho Mcneil Janssen Pharm DERIVATIVES OF 1,2,4-TRIAZOLO [4,3-A] PIRIDINE POSITIVE MODULATORS OF MGLUR2 RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSELVES AND USE OF THE SAME IN THE TREATMENT OF NEUROLOGICAL AND SYNCHIATRIC DISORDERS.
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
EP2496584B1 (en) * 2009-11-05 2016-09-21 Ambit Biosciences Corporation Process for the preparation of imidazo[2,1-b][1,3]benzothiazole derivatives
WO2011109398A2 (en) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
US20110294879A1 (en) 2010-05-28 2011-12-01 Xenoport, Inc. Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders
WO2012009646A1 (en) 2010-07-15 2012-01-19 Xenoport, Inc. Methods of treating fragile x syndrome, down's syndrome, autism and related disorders
PL2649069T3 (en) 2010-11-08 2016-01-29 Janssen Pharmaceuticals Inc 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
CN103298809B (en) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-triazol [4,3-a] pyridine derivate and the purposes of the positive allosteric modulators as MGLUR2 acceptor thereof
CA2814998C (en) 2010-11-08 2019-10-29 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
AU2015208233B2 (en) 2014-01-21 2019-08-29 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
PT3096790T (en) 2014-01-21 2019-10-15 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
US11559518B2 (en) * 2017-12-28 2023-01-24 Er Stress Research Institute, Inc. Endoplasmic reticulum stress regulator comprising benzothiazoimidazolyl compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2463774A1 (en) * 1979-08-21 1981-02-27 Yamanouchi Pharma Co Ltd DERIVATIVES OF 2-PHENYLIMIDAZO (2,1-B) BENZOTHIAZOLE
JPS56138196A (en) * 1980-03-29 1981-10-28 Yamanouchi Pharmaceut Co Ltd Imidazo (2,1-b)benzothiazole derivative
JPS5740492A (en) * 1980-08-22 1982-03-06 Yamanouchi Pharmaceut Co Ltd Novel 2-phenylimidazo 2,1-b benzothiazole derivative
JPS57149288A (en) * 1981-03-12 1982-09-14 Yamanouchi Pharmaceut Co Ltd Imidazo(2,1-b)benzothiazole derivative
US4464384A (en) * 1981-12-23 1984-08-07 Yamanouchi Pharmaceutical Co., Ltd. 2-Phenylimidazo[2,1-b]benzothiazole compounds, salts thereof, process of producing them, and pharmaceutical compositions containing them
EP0524055A1 (en) * 1991-07-19 1993-01-20 Synthelabo Imidazo(2,1-b)benzothiazole-3-acetamide derivatives, process for their preparation and their therapeutical use
FR2699920B1 (en) * 1992-12-24 1995-02-10 Synthelabo Imidazo [2,1-b] benzothiazole-3-acetamide derivatives, their preparation and their therapeutic use.
FR2699921B1 (en) * 1992-12-30 1995-02-10 Synthelabo 2- (Thien-2-yl) imidazo [2,1-b] benzothiazole-3-acetic acid derivatives, their preparation and their therapeutic use.
CA2185670A1 (en) * 1994-03-14 1995-09-21 Palle Jakobsen Heterocyclic compounds, their preparation and use

Also Published As

Publication number Publication date
WO1998006724A1 (en) 1998-02-19
AU3783497A (en) 1998-03-06

Similar Documents

Publication Publication Date Title
ID18708A (en) LIGAN METABOTROPIC GLUTAMATE RECEPTORS
ATE250583T1 (en) SUBSTITUTED 3-CYANOCINOLINES
EE9700264A (en) 1-Phenylpyrazole-3-carboxamides act on neurotensin receptors
ID23168A (en) VITRONEKTIN ANATAGONICAL RECEPTORS
DE59706073D1 (en) ADJUSTING
ID24583A (en) 1,2,3,4-TETRAHIDRONAFTALENA SUBSTITUTED SITES
FI970633A0 (en) glutamate receptor
DE59813487D1 (en) SUBSTITUTED 4-BENZOYL-PYRAZOLE
DE59809844D1 (en) headbox
DK0923562T3 (en) Substituted p-trifluoromethylphenyluracils
DE59707428D1 (en) SUBSTITUTED 1-METHYL-3-BENZYLURACILE
ATE275146T1 (en) SUBSTITUTED PYRAZOLE-3-YLBENZAZOLE
DE29713433U1 (en) Headbox
DE59710430D1 (en) SUBSTITUTED 4-BENZOYL-PYRAZOLE
BR9711681A (en) New m-all
DE59712222D1 (en) SUBSTITUTED PHENYLURACILE
DE59708674D1 (en) SUBSTITUTED 3-PHENYLPYRAZOLE
DE29713434U1 (en) Headbox
DE29613270U1 (en) Guy knot
ID24079A (en) AMINOHETEROXICLYLAMIDE SUBSTITUTED
DE59807877D1 (en) SUBSTITUTED 4-BENZOYL-PYRAZOLE
SE9703745D0 (en) New receptors
DE59810960D1 (en) SUBSTITUTED PHENYLURACILE
KR970007809U (en) sprayer
KR960029215U (en) Strong anchor